Genetic Testing
24
6
9
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (24)
Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study
Genetic Testing for All Breast Cancer Patients (GET FACTS)
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
Comparing Direct vs Indirect Methods for Cascade Screening
PITCH - Impacting Hereditary Cancer Testing
Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China
Universal Genetic Testing for Cancer Risk Reduction
Video Education With Result Dependent dIsclosure
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
Prospective Registry of Multiplex Testing (PROMPT)
Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education
Improving Genetic Medicine for Ethnic Minority Groups
Addressing Genomic Disparities in Cancer Survivors
The Moran AMD Genetic Testing Assessment Study
Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making
Engaging Adolescents in Decisions About Return of Genomic Research Results
Genetic Testing and Motivational Counseling for FH
Access to Genetic Information Leveraging Innovative Technology (AGILITY)
Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes
Clinical Application of Non-invasive PGT-A